Skip to main content
. 2019 Jun 26;19:198. doi: 10.1186/s12888-019-2181-9

Table 3.

Summary of adverse events

Quetiapine XR (n = 179)
Number of Patients (%) Number of AEs
AEs 171 (95.5%) 845
Drug-related AEs 159 (88.8%) 559
Deaths 0
SAEs 5 (2.8%) 6
Drug-related SAEs 2 (1.1%) 2
AEs leading to discontinuation 51 (28.5%) 64
Drug-related AEs leading to discontinuation 39 (21.8%) 49

AEs adverse events, SAEs serious adverse events